Characteristics of patients with asthma overprescribed short-acting beta-agonist (SABA) reliever inhalers stratified by blood eosinophil count in North East London: a cross-sectional observational study.
BACKGROUND: Overprescription of short-acting beta-agonist (SABA) inhalers and blood eosinophil count have strong associations with exacerbation risk in asthma. However, in the authors' recent publication only a minority of patients overprescribed SABA (≥6 inhalers in 12 months) were eosinophilic (≥0.3 x 109 cells/l). AIM: To compare the characteristics of eosinophilic and non-eosinophilic patients with asthma overprescribed SABA inhalers, and identify latent classes using clinical variables available in primary care. DESIGN & SETTING: Cross-sectional analysis of patients with asthma in Nor... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2023 |
Schlagwörter: | albuterol / asthma / general practice / primary health care / short-acting beta-agonist |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-28828594 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://qmro.qmul.ac.uk/xmlui/handle/123456789/85142 |